Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure

Heart Failure Reviews

Volumn 17, Issue 2, 2012, Pages 161-175

  Braam, Branko ^a,b   Cupples, William A ^c   Joles, Jaap A ^d   Gaillard, Carlo ^e,f  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Medicine/Nephrology   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heart failure; Renal autoregulation; Renal hemodynamics; Renal venous pressure; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

ADENOSINE A1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; FUROSEMIDE; LOOP DIURETIC AGENT; METOPROLOL; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NEUROHORMONE; NITRIC OXIDE; PLACEBO; PRAZOSIN; RENIN INHIBITOR; ROLOFYLLINE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; URODILATIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ADRENERGIC SYSTEM; ANGIOPLASTY; AUTOREGULATION; CLINICAL RESEARCH; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; EXTRACELLULAR SPACE; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HORMONAL REGULATION; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY TUBULE PRESSURE; KIDNEY VASCULAR RESISTANCE; LIVER FUNCTION; LOW DRUG DOSE; LUNG EDEMA; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; SIDE EFFECT; SODIUM RESTRICTION; ULTRAFILTRATION; UNSPECIFIED SIDE EFFECT; WATER DEPRIVATION;

ARTERIES; GLOMERULAR FILTRATION RATE; HEART; HEART FAILURE; HEMODYNAMICS; HUMANS; KIDNEY; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; VEINS;

EID: 84860849357     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9246-2     Document Type: Review

References (120)

1. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 26:11-17
2. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527-1539
3. El Nahas M (2010) Cardio-kidney-damage: a unifying concept. Kidney Int 78:14-18
4. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582-588
5. Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589-596
6. Udani SM, Koyner JL (2010) The effects of heart failure on renal function. Cardiol Clin 28:453-465
7. Deen WM, Robertson CR, Brenner BM (1972) A model of glomerular ultrafiltration in the rat. Am J Physiol 223: 1178-1183
8. Gabbai FB, Gushwa LC, Peterson OW, Wilson CB, Blantz RC (1987) Analysis of renal function in the two-kidney Goldblatt model. Am J Physiol 252:F131-F137
9. Schnermann J, Wright FS, Davis JM, von Stackelberg W, Grill G (1970) Regulation of superficial nephron filtration rate by tubulo-glomerular feedback. Pflugers Arch 318:147-175
10. Braam B, Navar LG, Mitchell KD (1995) Modulation of tubuloglomerular feedback by angiotensin II type 1 receptors during the development of Goldblatt hypertension. Hypertension 25:1232-1237
11. Oken DE (1982) An analysis of glomerular dynamics in rat, dog, and man. Kidney Int 22:136-145
12. Bayliss WM (1902) On the local reactions of the arterial wall to changes of internal pressure. J Physiol 28:220-231
13. Cupples WA, Braam B (2007) Assessment of renal autoregulation. Am J Physiol Renal Physiol 292:F1105-F1123
14. Just A, Arendshorst WJ (2003) Dynamics and contribution of mechanisms mediating renal blood flow autoregulation. Am J Physiol Regul Integr Comp Physiol 285:R619-R631
15. Siu KL, Sung B, Cupples WA, Moore LC, Chon KH (2009) Detection of low-frequency oscillations in renal blood flow. Am J Physiol Renal Physiol 297:F155-F162
16. Carmines PK, Inscho EW, Gensure RC (1990) Arterial pressure effects on preglomerular microvasculature of juxtamedullary nephrons. Am J Physiol 258:F94-F102
17. Loutzenhiser R, Bidani A, Chilton L (2002) Renal myogenic response: kinetic attributes and physiological role. Circ Res 90:1316-1324
18. Braam B, Mitchell KD, Koomans HA, Navar LG (1993) Relevance of the tubuloglomerular feedback mechanism in pathophysiology. J Am Soc Nephrol 4:1257-1274
19. Schnermann J, Traynor T, Yang T et al (1998) Tubuloglomerular feedback: new concepts and developments. Kidney Int Suppl 67:S40-S45
20. Vallon V (2003) Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol Sci 18:169-174
21. Kriz W (2004) Adenosine and ATP: traffic regulators in the kidney. J Clin Invest 114:611-613
22. Schnermann J, Weihprecht H, Briggs JP (1990) Inhibition of tubuloglomerular feedback during adenosine1 receptor blockade. Am J Physiol 258:F553-F561
23. Sun D, Samuelson LC, Yang T et al (2001) Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A 98: 9983-9988
24. Leyssac PP, Karlsen FM, Holstein-Rathlou NH, Skott O (1994) On determinants of glomerular filtration rate after inhibition of proximal tubular reabsorption. Am J Physiol 266:R1544-R1550
25. Skott P, Hommel E, Bruun NE, Arnold-Larsen S, Parving HH (1989) The acute effect of acetazolamide on glomerular filtration rate and proximal tubular reabsorption of sodium and water in normal man. Scand J Clin Lab Invest 49:583-587
26. Carmines PK, Morrison TK, Navar LG (1986) Angiotensin II effects on microvascular diameters of in vitro blood-perfused juxtamedullary nephrons. Am J Physiol 251:F610-F618
27. Carmines PK, Perry MD, Hazelrig JB, Navar LG (1987) Effects of preglomerular and postglomerular vascular resistance alterations on filtration fraction. Kidney Int Suppl 20:S229-S232
28. Mitchell KD, Braam B, Navar LG (1992) Hypertensinogenic mechanisms mediated by renal actions of renin-angiotensin system. Hypertension 19:I18-I27
29. Braam B, Koomans HA (1996) Renal responses to antagonism of the renin-angiotensin system. Curr Opin Nephrol Hypertens 5:89-96
30. DiBona GF, Sawin LL (2004) Effect of renal denervation on dynamic autoregulation of renal blood flow. Am J Physiol Renal Physiol 286:F1209-F1218
31. Rudenstam J, Bergstrom G, Taghipour K, Gothberg G, Karlstrom G (1995) Efferent renal sympathetic nerve stimulation in vivo. Effects on regional renal haemodynamics in the Wistar rat, studied by laser-Doppler technique. Acta Physiol Scand 154: 387-394
32. DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77:75-197
33. Takabatake T (1982) Feedback regulation of glomerular filtration rate in the denervated rat kidney. Kidney Int Suppl 12:S129-S135
34. Hermansson K, Kallskog O, Wolgast M (1984) Effect of renal nerve stimulation on the activity of the tubuloglomerular feedback mechanism. Acta Physiol Scand 120:381-385
35. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr (2008) Biology of the natriuretic peptides. Am J Cardiol 101:3-8
36. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321-328
37. Gaillard CA, Koomans HA, Mees EJ (1988) Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension 11:160-165
38. Nishikimi T, Miura K, Minamino N, Takeuchi K, Takeda T (1994) Role of endogenous atrial natriuretic peptide on systemic and renal hemodynamics in heart failure rats. Am J Physiol 267:H182-H186
39. Baylis C, Harton P, Engels K (1990) Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1:875-881
40. Baylis C, Mitruka B, Deng A (1992) Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90:278-281
41. Zatz R, de Nucci G (1991) Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 261: F360-F363
42. Kramp RA, Fourmanoir P, Ladriere L et al (2000) Effects of Ca(2+) channel activity on renal hemodynamics during acute attenuation of NO synthesis in the rat. Am J Physiol Renal Physiol 278:F561-F569
43. Kramp R, Fourmanoir P, Caron N (2001) Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat. Am J Physiol Renal Physiol 281:F1132-F1140
44. Turkstra E, Braam B, Koomans HA (2000) Impaired renal blood flow autoregulation in two-kidney, one-clip hypertensive rats is caused by enhanced activity of nitric oxide. J Am Soc Nephrol 11:847-855
45. Shi Y, Wang X, Chon KH, Cupples WA (2006) Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide. Am J Physiol Regul Integr Comp Physiol 290:R982-R991
46. Braam B, Koomans HA (1995) Reabsorption of nitro-L-arginine infused into the late proximal tubule participates in modulation of TGF responsiveness. Kidney Int 47:1252-1257
47. Braam B, Koomans HA (1995) Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness. Kidney Int 48:1406-1411
48. Haas GJ, Leier CV (2009) Are hemodynamic parameters predictors of mortality? Heart Fail Clin 5:229-240
49. Cody RJ, Ljungman S, Covit AB et al (1988) Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34:361-367
50. Smilde TD, Damman K, van der Harst P et al (2009) Differential associations between renal function and "modifiable" risk factorsin patients with chronic heart failure. Clin Res Cardiol 98:121-129
51. Robertson CR, Deen WM, Troy JL, Brenner BM (1972) Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol 223:1191-1200
52. Schunkert H, Tang SS, Litwin SE et al (1993) Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res 27:731-735
53. Patel KP (2000) Role of paraventricular nucleus in mediating sympathetic outflow in heart failure. Heart Fail Rev 5:73-86
54. Myers BD, Deen WM, Brenner BM (1975) Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101-110
55. Fleming JT, Zhang C, Chen J, Porter JP (1992) Selective preglomerular constriction to nerve stimulation in rat hydronephrotic kidneys. Am J Physiol 262:F348-F353
56. Weidmann P, Beretta-Piccoli C, Steffen F, Blumberg A, Reubi FC (1976) Hypertension in terminal renal failure. Kidney Int 9:294-301
57. Ligtenberg G, Blankestijn PJ, Oey PL et al (1999) Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340:1321-1328
58. Braam B (1999) Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume. Am J Physiol 276:R1551-R1561
59. Navar LG (1998) Integrating multiple paracrine regulators of renal microvascular dynamics. Am J Physiol 274:F433-F444
60. Osswald H, Spielman WS, Knox FG (1978) Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res 43:465-469
61. Osswald H, Hermes HH, Nabakowski G (1982) Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int Suppl 12:S136-S142
62. Massie BM, O'Connor CM, Metra M et al (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419-1428
63. Oghlakian G, Klapholz M (2009) Vasopressin and vasopressin receptor antagonists in heart failure. Cardiol Rev 17:10-15
64. Fitzsimons JT (1998) Angiotensin, thirst, and sodium appetite. Physiol Rev 78:583-686
65. Winton FR (1931) The influence of venous pressure on the isolated mammalian kidney. J Physiol 72:49-61
66. Maxwell MH, Breed ES, Schwartz IL (1950) Renal venous pressure in chronic congestive heart failure. J Clin Invest 29:342-348
67. Jessup M, Costanzo MR (2009) The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol 53:597-599
68. Joles JA, Bongartz LG, Gaillard CA, Braam B (2009) Renal venous congestion and renal function in congestive heart failure. J Am Coll Cardiol 54:1632; author reply 1632-1633
69. Blake WD, Wegria R et al (1949) Effect of increased renal venous pressure on renal function. Am J Physiol 157:1-13
70. Gottschalk CW, Mylle M (1956) Micropuncture study of pressures in proximal tubules and peritubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures. Am J Physiol 185:430-439
71. Doty JM, Saggi BH, Sugerman HJ et al (1999) Effect of increased renal venous pressure on renal function. J Trauma 47:1000-1003
72. Semple SJ, De Wardener HE (1959) Effect of increased renal venous pressure on circulatory autoregulation of isolated dog kidneys. Circ Res 7:643-648
73. Clausen G, Oien AH, Aukland K (1992) Myogenic vasoconstriction in the rat kidney elicited by reducing perirenal pressure. Acta Physiol Scand 144:277-290
74. Gudmundsson FF, Gislason HG, Myking OL, Viste A, Grong K, Svanes K (2002) Hormonal changes related to reduced renal blood flow and low urine output under prolonged increased intra-abdominal pressure in pigs. Eur J Surg 168:178-186
75. Kishimoto T, Maekawa M, Abe Y, Yamamoto K (1973) Intrarenal distribution of blood flow and renin release during renal venous pressure elevation. Kidney Int 4:259-266
76. Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ (1997) Elevated intra-abdominal pressure increases plasma rennin activity and aldosterone levels. J Trauma 42:997-1004, discussion 1004-1005
77. van Onna M, Houben AJ, Kroon AA et al (2003) Asymmetry of renal blood flow in patients with moderate to severe hypertension. Hypertension 41:108-113
78. Bax L, Woittiez AJ, Kouwenberg HJ et al (2009) Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 150(840-8):W150-W151
79. Wheatley K, Ives N, Gray R et al (2009) Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 361:1953-1962
80. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA (2005) Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol 16:2746-2753
81. Emans ME, Van Der Putten K, Velthuis BK et al (2009) High prevalence of atherosclerotic renal artery stenosis in the cardiorenal syndrome; negative association with diabetes mellitus posterpresentatie. European Society of Cardiology, Barcelona
82. Kalra PA (2010) Renal revascularization for heart failure in patients with atherosclerotic renovascular disease. Nephrol Dial Transplant 25:661-663
83. Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD (2009) Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 25:813-820
84. Wolf G (2008) Novel aspects of the renin-angiotensin-aldosterone-system. Front Biosci 13:4993-5005
85. Danser AH (2007) Novel drugs targeting hypertension: rennin inhibitors. J Cardiovasc Pharmacol 50:105-111
86. Ma TK, Kam KK, Yan BP, Lam YY (2010) Renin-angiotensinaldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 160:1273-1292
87. Muller DN, Luft FC (2008) Renin receptor blockade: a better strategy for renal protection than renin-angiotensin system inhibition? Curr Hypertens Rep 10:405-409
88. Burns KD (2007) The emerging role of angiotensin-converting enzyme-2 in the kidney. Curr Opin Nephrol Hypertens 16: 116-121
89. Erdos EG, Yang HY (1967) An enzyme in microsomal fraction of kidney that inactivates bradykinin. Life Sci 6:569-574
90. Pellacani A, Brunner HR, Nussberger J (1994) Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci (Lond) 87:567-574
91. Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE (2004) Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin- converting enzyme inhibition in patients with heart failure. Arterioscler Thromb Vasc Biol 24:1043-1048
92. Haddad G, Amiri F, Garcia R (1997) Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism. Regul Pept 68:111-117
93. Rosivall L, Youngblood P, Navar LG (1986) Renal autoregulatory efficiency during angiotensin-converting enzyme inhibition in dogs on a low sodium diet. Ren Physiol 9:18-28
94. Cupples WA (1993) Angiotensin II conditions the slow component of autoregulation of renal blood flow. Am J Physiol 264:F515-F522
95. Sorensen CM, Leyssac PP, Skott O, Holstein-Rathlou NH (2000) Role of the renin-angiotensin system in regulation and autoregulation of renal blood flow. Am J Physiol Regul Integr Comp Physiol 279:R1017-R1024
96. Ito H, Nagatomo Y, Kohno T, et al (2010) Differential effects of carvedilol and metoprolol on renal function in patients with heart failure. Circ J 74:1578-1583
97. Heitmann M, Davidsen U, Stokholm KH, Rasmussen K, Burchardt H, Petersen EB (2002) Renal and cardiac function during alpha1-beta-blockade in congestive heart failure. Scand J Clin Lab Invest 62:97-104
98. Preston RA, O'Connor DT, Stone RA (1979) Prazosin and renal hemodynamics: arteriolar vasodilation during therapy of essential hypertension in man. J Cardiovasc Pharmacol 1:277-286
99. Magorien RD, Hermiller JB, Unverferth DV, Leier CV (1985) Regional hemodynamic effects of clonidine in congestive heart failure. J Cardiovasc Pharmacol 7:91-96
100. Schlatter E, Salomonsson M, Persson AE, Greger R (1989) Macula densa cells sense luminal NaCl concentration via furosemide sensitive Na+2Cl-K+ cotransport. Pflugers Arch 414:286-290
101. Oppermann M, Hansen PB, Castrop H, Schnermann J (2007) Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice. Am J Physiol Renal Physiol 293:F279-F287
102. Wang X, Breaks J, Loutzenhiser K, Loutzenhiser R (2007) Effects of inhibition of the Na+/K+/2Cl-cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole. Am J Physiol Renal Physiol 292:F999-F1006
103. Paterna S, Parrinello G, Cannizzaro S et al (2009) Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol 103:93-102
104. Good JM, Brady AJ, Noormohamed FH, Oakley CM, Cleland JG (1994) Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition. Circulation 90:220-224
105. Motwani JG, Fenwick MK, Morton JJ, Struthers AD (1992) Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. Circulation 86:439-445
106. Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJ (1973) Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288:1087-1090
107. Beck FX, Sone M, Dorge A, Thurau K (1992) Effect of loop diuretics on organic osmolytes and cell electrolytes in the renal outer medulla. Kidney Int 42:843-850
108. MacFadyen RJ, Ng Kam Chuen MJ, Davis RC (2010) Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy? Eur J Heart Fail 12:649-652
109. Slagman MC, Navis G, Laverman GD (2010) Reversible effects of diuretics added to renin-angiotensin-aldosterone system blockade: impact on interpretation of long-term kidney function outcome. Am J Kidney Dis 56:601-602
110. Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160:685-693
111. Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797-805
112. Sihm I, Thygesen K, Krusell LR, Lederballe O (2000) Longterm renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide. Blood Press 9:346-354
113. Walsh JT, Andrews R, Curtis S, Evans A, Cowley AJ (1997) Effects of amlodipine in patients with chronic heart failure. Am Heart J 134:872-878
114. Drexler H, Depenbusch JW, Truog AG, Zelis R, Flaim SF (1985) Effects of diltiazem on cardiac function and regional blood flow at rest and during exercise in a conscious rat preparation of chronic heart failure (myocardial infarction). Circulation 71:1262-1270
115. Binetti G, Rubino I, Varani E et al (1989) Felodipine in severe chronic congestive heart failure: acute effects on central hemodynamics and regional blood flow distribution. Cardiovasc Drugs Ther 3:903-911
116. Mitrovic V, Seferovic P, Dodic S et al (2009) Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure. Circ Heart Fail 2:523-531
117. Veeraveedu PT, Watanabe K, Ma M et al (2008) Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Biochem Pharmacol 75:1322-1330
118. Costello-Boerrigter LC, Boerrigter G, Cataliotti A, Harty GJ, Burnett JC Jr (2010) Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure. Circ Heart Fail 3:412-419
119. Mathier MA, Ishizawar D (2010) Bosentan. Expert Opin Pharmacother 11:1023-1034
120. Hall JE, Coleman TG, Guyton AC, Kastner PR, Granger JP (1981) Control of glomerular filtration rate by circulating angiotensin II. Am J Physiol 241:R190-R197